You are logged on as Guest.
RegisterLoginShopping cart (Empty)
 United States

Aurintricarboxylic acid

Topoisomerase II inhibitor
 
ALX-270-201-G001 1 g 30.00 USD
 
Potent inhibitor of DNA topoisomerase II in vitro and protein-nucleic acid interactions. Stimulates the tyrosine phosphorylation of MAP kinases. Inhibits both major calpain isoforms. Potent and selective inhibitor of SARS coronavirus replication. Apoptosis inhibitor.

Product Specification

Alternative Name:ATA
 
Formula:C22H14O9
 
MW:422.4
 
Purity:~85%
 
Appearance:Red solid.
 
CAS:4431-00-9
 
Solubility:Soluble in aqueous alkali.
 
Long Term Storage:+20°C
 
Hazard:IRRITANT.
 
ALX-270-201
Please mouse over
ALX-270-201

Product Literature References

Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid: R. He, et al.; BBRC 320, 1199 (2004), Abstract;
A neuroprotective compound, aurin tricarboxylic acid, stimulates the tyrosine phosphorylation cascade in PC12 cells: N. Okada & S. Koizumi; J. Biol. Chem. 270, 16464 (1995), Abstract; Full Text
Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells: Y. Benchokroun, et al.; Biochem. Pharmacol. 49, 305 (1995), Abstract;
Delayed application of aurintricarboxylic acid reduces glutamate- induced cortical neuronal injury: C.A. Csernansky, et al.; J. Neurosci. Res. 38, 101 (1994), Abstract;
Inhibition of topoisomerase II by aurintricarboxylic acid: implications for mechanisms of apoptosis: D.R. Catchpoole & B.W. Stewart; Anticancer Res. 14, 853 (1994), Abstract;
Mechanism of action of polymeric aurintricarboxylic acid, a potent inhibitor of protein--nucleic acid interactions: R.G. Gonzalez, et al.; Biochemistry 19, 4299 (1980), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet 
MSDS 

RELATED PRODUCTS

By catalog section:
By biological activity:
Topoisomerase Inhibitor

PRODUCT SUPPORT

Technical Service
Bulk Quantity Quote
Customer Service
©2010 Enzo Life Sciences, Inc.,